AstraZeneca booster dose of our vaccine enhances the ability to resist Omicron

AstraZeneca said today, Thursday, that preliminary data from a trial of its vaccine against Covid-19 showed that a third booster dose of it generates a greater antibody response against Omicron and other mutated strains of the Corona virus, including beta, delta, alpha and gamma.

The global pharmaceutical company said that the increased response was observed in those who were previously vaccinated with either its vaccine or one of the vaccines that rely on messenger RNA technology.

It added that it will send this data to regulators around the world due to the urgent need for the booster doses.

AstraZeneca produced the vaccine in cooperation with researchers from Oxford University, and laboratory studies last month found that injections of three doses of AstraZeneca vaccine were effective in resisting the new, fast-spreading Omicron mutant.

And the data is the first that the company announces from its experiments on the booster dose of its vaccine.

A large British trial in December found that a booster dose of AstraZeneca increased antibodies after an initial vaccination with the same vaccine or with Pfizer’s messenger RNA technology.

Leave a Comment


No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published.